Modulation of chemokine gene expression by Shiga-toxin producing Escherichia coli belonging to various origins and serotypes

Microbes and Infection

Volumn 10, Issue 2, 2008, Pages 159-165

  Gobert, Alain P ^a   Coste, Alix ^a   Guzman, Carlos A ^b   Vareille, Marjolaine ^a   Hindré, Thomas ^a   de Sablet, Thibaut ^a   Girardeau, Jean Pierre ^a   Martin, Christine ^a  

^a CEMAGREF   (France)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Chemokine; Epithelial cells; Flagellin; Locus of enterocyte effacement; Shiga toxin producing Escherichia coli

Indexed keywords

BACTERIAL PROTEIN; CHEMOKINE; FLAGELLIN; FLAGELLIN H10; FLAGELLIN H21; FLAGELLIN H7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL STIMULATION; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MUCOSAL IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ADHESINS, BACTERIAL; ANIMALS; CATTLE; CATTLE DISEASES; CELL LINE; CHEMOKINES; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLAGELLIN; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE TRANSPORT PROTEINS; PHOSPHOPROTEINS; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); BOS; ESCHERICHIA COLI;

EID: 39749195578     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.10.018     Document Type: Article

References (35)

1. Paton J.C., and Paton A.W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11 (1998) 450-479
2. Tarr P.I., Gordon C.A., and Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365 (2005) 1073-1086
3. Boerlin P., McEwen S.A., Boerlin-Petzold F., Wilson J.B., Johnson R.P., and Gyles C.L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37 (1999) 497-503
4. Besser T.E., Shaikh N., Holt N.J., Tarr P.I., Konkel M.E., Malik-Kale P., Walsh C.W., Whittam T.S., and Bono J.L. Greater diversity of Shiga toxin-encoding bacteriophage insertion sites among Escherichia coli O157:H7 isolates from cattle than in those from humans. Appl. Environ. Microbiol. 73 (2007) 671-679
5. Kenny B., and Finlay B.B. Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-gamma1. Infect. Immun 65 (1997) 2528-2536
6. Jerse A.E., Yu J., Tall B.D., and Kaper J.B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. USA 87 (1990) 7839-7843
7. Knutton S., Rosenshine I., Pallen M.J., Nisan I., Neves B.C., Bain C., Wolff C., Dougan G., and Frankel G. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J 17 (1998) 2166-2176
8. Kresse A.U., Rohde M., and Guzman C.A. The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells. Infect. Immun 67 (1999) 4834-4842
9. Kresse A.U., Beltrametti F., Muller A., Ebel F., and Guzman C.A. Characterization of SepL of enterohemorrhagic Escherichia coli. J. Bacteriol 182 (2000) 6490-6498
10. Kresse A.U., Schulze K., Deibel C., Ebel F., Rohde M., Chakraborty T., and Guzman C.A. Pas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli. J. Bacteriol 180 (1998) 4370-4379
11. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., and Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem 171 (1988) 45-50
12. Smith W.E., Kane A.V., Campbell S.T., Acheson D.W., Cochran B.H., and Thorpe C.M. Shiga toxin 1 triggers a ribotoxic stress response leading to p38 and JNK activation and induction of apoptosis in intestinal epithelial cells, Infect. Immun 71 (2003) 1497-1504
13. Gobert A.P., Vareille M., Glasser A.L., Hindre T., de Sablet T., and Martin C. Shiga-toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-κB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J. Immunol 178 (2007) 8168-8174
14. Robinson C.M., Sinclair J.F., Smith M.J., and O'Brien A.D. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc. Natl. Acad. Sci. USA 103 (2006) 9667-9672
15. Fitzpatrick M.M., Shah V., Trompeter R.S., Dillon M.J., and Barratt T.M. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42 (1992) 951-956
16. Gobert A.P., Wilson K.T., and Martin C. Cellular responses to attaching and effacing bacteria: activation and implication of the innate immune system. Arch. Immunol. Ther. Exp. 53 (2005) 234-244
17. Griffin P.M., Olmstead L.C., and Petras R.E. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology 99 (1990) 142-149
18. Dahan S., Busuttil V., Imbert V., Peyron J.F., Rampal P., and Czerucka D. Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-κB and AP-1 in T84 cells. Infect. Immun 70 (2002) 2304-2310
19. Lindgren S.W., Melton A.R., and O'Brien A.D. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun 61 (1993) 3832-3842
20. Pradel N., Livrelli V., De Champs C., Palcoux J.B., Reynaud A., Scheutz F., Sirot J., Joly B., and Forestier C. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J. Clin. Microbiol. 38 (2000) 1023-1031
21. Perna N.T., Plunkett III G., Burland V., Mau B., Glasner J.D., Rose D.J., Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A., Posfai G., Hackett J., Klink S., Boutin A., Shao Y., Miller L., Grotbeck E.J., Davis N.W., Lim A., Dimalanta E.T., Potamousis K.D., Apodaca J., Anantharaman T.S., Lin J., Yen G., Schwartz D.C., Welch R.A., and Blattner F.R. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409 (2001) 529-533
22. Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K., Han C.G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T., Iida T., Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T., Kuhara S., Shiba T., Hattori M., and Shinagawa H. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 8 (2001) 11-22
23. Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97 (2000) 6640-6645
24. Beltrametti F., Kresse A.U., and Guzman C.A. Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli. J. Bacteriol 181 (1999) 3409-3418
25. Czerucka D., Dahan S., Mograbi B., Rossi B., and Rampal P. Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect. Immun 69 (2001) 1298-1305
26. Berin M.C., Darfeuille-Michaud A., Egan L.J., Miyamoto Y., and Kagnoff M.F. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-κB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell. Microbiol. 4 (2002) 635-648
27. Garmendia J., Phillips A.D., Carlier M.F., Chong Y., Schüller S., Marches O., Dahan S., Oswald E., Shaw R.K., Knutton S., and Frankel G. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell. Microbiol. 6 (2004) 1167-1183
28. Rogers T.J., Paton A.W., McColl S.R., and Paton J.C. Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli. Infect. Immun 71 (2003) 5623-5632
29. Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., and Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol 4 (2003) 1247-1253
30. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., and Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol 167 (2001) 1882-1885
31. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., and Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol 167 (2001) 1609-1616
32. Melmed G., Thomas L.S., Lee N., Tesfay S.Y., Lukasek K., Michelsen K.S., Zhou Y., Hu B., Arditi M., and Abreu M.T. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol 170 (2003) 1406-1415
33. Hisamatsu T., Suzuki M., and Podolsky D.K. Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J. Biol. Chem. 278 (2003) 32962-32968
34. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., and Podolsky D.K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-κB activation in muramyl dipeptide recognition. J. Cell. Biol. 170 (2005) 21-26
35. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., and Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol 5 (2004) 1166-1174